Ancient genomic linkage couples metabolism with erythroid development

The process of generating mature blood cells from progenitors demands precise coordination between cell differentiation and metabolic activity. Erythropoiesis, specifically, involves erythroblasts increasing globin production and undergoing enucleation to form mature red blood cells. The gene Nprl3 has been found in close genomic proximity to α-globin genes for over half a billion years. It also contains most of the α-globin enhancer elements. Nprl3 is known to inhibit mTORC1, a key regulator of cellular metabolism. However, its role in erythroid development remains unclear. Prior research has shown that mTORC1 controls metabolic processes, but its connection to erythropoiesis is not fully understood. The function of α-globin enhancers in regulating Nprl3 is also underexplored. This gap motivated a deeper investigation into how Nprl3 might influence erythroid development and metabolism. Understanding this could reveal how erythropoiesis adapts to changing metabolic conditions.

This study aimed to determine whether Nprl3 plays a role in erythroid development and metabolism. The researchers sought to investigate how Nprl3 might regulate mTORC1 signaling in erythroblasts. They also wanted to assess the impact of Nprl3 deficiency on erythropoiesis. The study aimed to clarify if Nprl3 is necessary for proper enucleation and red blood cell production. The researchers were particularly interested in the interaction between Nprl3 and α-globin enhancers. They wanted to understand how this genomic linkage might influence erythroid development. The motivation stemmed from the long evolutionary conservation of Nprl3 and α-globin genes. This study aimed to bridge the gap between metabolic regulation and erythroid differentiation.

The researchers used Nprl3-deficient fetal liver and adult bone marrow-fetal liver chimeras to assess erythropoiesis. They analyzed mTORC1 signaling, autophagy, glycolysis, and redox control in these models. Human CD34+ progenitor cells lacking NPRL3 were also studied to evaluate enucleation and mTORC1 activity. The team measured how these cells responded to varying nutrient levels and erythropoietin. They examined the role of α-globin enhancers in regulating Nprl3 expression. The study included both in vivo and in vitro experiments to validate findings. Researchers used competitive bone marrow chimeras to compare wild-type and Nprl3-deficient cells. They focused on how the absence of Nprl3 affects erythroid development and metabolic pathways.

Nprl3 deficiency reduced erythropoiesis in fetal liver and adult bone marrow chimeras. Loss of Nprl3 increased mTORC1 signaling and suppressed autophagy in erythroblasts. This disruption also affected glycolysis and redox control in these cells. Human CD34+ progenitors without NPRL3 produced fewer enucleated cells. These cells showed dysregulated mTORC1 signaling in response to nutrients and erythropoietin. The α-globin enhancers were found to upregulate Nprl3 expression. This upregulation was necessary for optimal erythropoiesis. The study demonstrated that the genomic linkage between Nprl3 and α-globin is functionally significant.

The study suggests that Nprl3 is a key regulator of erythroid metabolism. The researchers propose that Nprl3 helps coordinate mTORC1 signaling, autophagy, and redox control during erythropoiesis. The genomic linkage between Nprl3 and α-globin appears to be functionally important. This linkage may help synchronize metabolic and developmental processes in erythroid cells. The study supports the idea that this ancient genomic connection enables erythropoiesis to adapt to environmental and nutritional changes. The findings indicate that Nprl3 is necessary for sufficient erythropoiesis. The researchers suggest that the α-globin enhancers regulate Nprl3 expression to support optimal red blood cell production. These conclusions are based on the observed effects of Nprl3 deficiency in both mouse and human models.